Drug Discovery
In this section you will find Drug Discovery market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Antibacterial Drugs: Commercial Prospects 2011-2026
$2,739.00Published by Visiongain on Jan 12th, 2011what will this decade hold for that industry and market? How will the antibacterial drug sector develop from 2011, and where can you find opportunities there? We show you prospects... Learn More -
Innovations in Delivery Methods for Nutraceutical Food and Drinks
$3,835.00Published by Business Insights on Jan 7th, 2011This report explores the range of manufacturing technologies that are available for encapsulating ingredients to change their performance characteristics. The report focuses on innovation and the companies with the expertise... Learn More -
The Drug Discovery Outsourcing Market
$3,835.00Published by Business Insights on Jan 7th, 2011This report investigates current trends and opportunities affecting decisions on whether or not to outsource drug discovery. Outsourcing to low cost offshore destinations such as China and India are examined... Learn More -
Innovative Drug Discovery in Emerging Markets
$3,835.00Published by Business Insights on Dec 13th, 2010Emerging markets have represented important growth opportunities for the global pharmaceutical industry, but it has been unclear the extent to which this has been accompanied by growth in domestic innovation... Learn More -
Pharmaceutical Stability Testing: Commercial Prospects 2011-2025
$2,461.00Published by Visiongain on Nov 24th, 2010where you can find the opportunities there How will the pharma stability testing sector develop from 2010, and where can you find the greatest opportunities there? How will technology suppliers... Learn More -
The Future of the Generics Industry: Opportunities, threats and key trends
$3,835.00Published by Business Insights on Aug 25th, 2010Driven by rising demand, patent expiries and pharmaceutical cost-containment policies, generic sales have risen consistently at rates in excess of the pharmaceutical industry average over the past decade. Coupled... Learn More -
R&D Drug Pipeline Database: 2-Months Subscription
$2,800.00Published by LaMerie on Aug 10th, 2010R&D Drug Pipeline Database: 2-Months Subscription
Product description
Subscription to La Merie’s proprietary R&D Drug Pipeline Database provides online access to more than 12,000... Learn More -
R&D Drug Pipeline Database: 1-Year Subscription
$8,400.00Published by LaMerie on Aug 2nd, 2010R&D Drug Pipeline Database: 1-Year Subscription
Product description
Subscription to La Merie’s proprietary R&D Drug Pipeline Database provides online access to more than 12,000... Learn More -
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 4th Edition
$3,995.00Published by Kalorama Information on Jun 1st, 2010Kalorama Information’s Outsourcing in Drug Discovery offers unparalleled discussion of the drug discovery outsourcing market. It presents viewpoints from both customers and suppliers. Segments, size, and growth of the market... Learn More -
Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025
$2,461.00Published by Visiongain on May 5th, 2010In 2009, the biological (biologic) drug market generated over $125bn in revenues worldwide. There is great demand for lower-cost biological drugs. Commercial and regulatory developments will make biosimilars and... Learn More -
The Future of GPCRs in Drug Discovery: Novel technologies, leading companies, and opportunities for target expansion
$3,835.00Published by Business Insights on Apr 1st, 2010G-protein coupled receptors (GPCRs) constitute the largest, most ubiquitous, and most versatile family of membrane receptors. They also constitute the class of targets that has been most effectively exploited... Learn More -
Preclinical Models: Innovative solutions to accelerate drug discovery and development
$3,835.00Published by Business Insights on Feb 10th, 2010Preclinical models are developed to test lead compounds for toxicity and efficacy. They are valuable tools to minimize development costs and reduce failures prior to commencement of human trials. Problems... Learn More -
The Global Active Pharmaceutical Ingredients (API) Market: Evaluating challenges, opportunities, innovations and the market environment
$3,835.00Published by Business Insights on Feb 9th, 2010Active pharmaceutical ingredients (APIs), also known as ’bulk drug substances’, are defined by the US Food and Drugs Administration (FDA) as ’any substance or mixture of substances intended to be... Learn More -
Statins: The World Market 2010-2025
$2,461.00Published by Visiongain on Feb 8th, 2010The world statins market is facing rapid change. From 2010 onwards, there will be major patent expires - most notably for Lipitor - maturity of products, and rising competition from generic alternatives. Learn More -
Cytotoxic Therapies Market Forecast
$15,200.00Published by Datamonitor on Jun 29th, 2009The cytotoxics market is mature and characterized by an increasing level of genericization. Several blockbuster products will undergo patent expiry during the forecast period, however, by virtue of these drugs’ success, generic entry will ensure continued growth. Learn More
Drug Discovery
In this section you will find Drug Discovery market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Antibacterial Drugs: Commercial Prospects 2011-2026
$2,739.00Published by Visiongain on Jan 12th, 2011what will this decade hold for that industry and market? How will the antibacterial drug sector develop from 2011, and where can you find opportunities there? We show you prospects... Learn More -
Innovations in Delivery Methods for Nutraceutical Food and Drinks
$3,835.00Published by Business Insights on Jan 7th, 2011This report explores the range of manufacturing technologies that are available for encapsulating ingredients to change their performance characteristics. The report focuses on innovation and the companies with the expertise... Learn More -
The Drug Discovery Outsourcing Market
$3,835.00Published by Business Insights on Jan 7th, 2011This report investigates current trends and opportunities affecting decisions on whether or not to outsource drug discovery. Outsourcing to low cost offshore destinations such as China and India are examined... Learn More -
Innovative Drug Discovery in Emerging Markets
$3,835.00Published by Business Insights on Dec 13th, 2010Emerging markets have represented important growth opportunities for the global pharmaceutical industry, but it has been unclear the extent to which this has been accompanied by growth in domestic innovation... Learn More -
Pharmaceutical Stability Testing: Commercial Prospects 2011-2025
$2,461.00Published by Visiongain on Nov 24th, 2010where you can find the opportunities there How will the pharma stability testing sector develop from 2010, and where can you find the greatest opportunities there? How will technology suppliers... Learn More -
The Future of the Generics Industry: Opportunities, threats and key trends
$3,835.00Published by Business Insights on Aug 25th, 2010Driven by rising demand, patent expiries and pharmaceutical cost-containment policies, generic sales have risen consistently at rates in excess of the pharmaceutical industry average over the past decade. Coupled... Learn More -
R&D Drug Pipeline Database: 2-Months Subscription
$2,800.00Published by LaMerie on Aug 10th, 2010R&D Drug Pipeline Database: 2-Months Subscription
Product description
Subscription to La Merie’s proprietary R&D Drug Pipeline Database provides online access to more than 12,000... Learn More -
R&D Drug Pipeline Database: 1-Year Subscription
$8,400.00Published by LaMerie on Aug 2nd, 2010R&D Drug Pipeline Database: 1-Year Subscription
Product description
Subscription to La Merie’s proprietary R&D Drug Pipeline Database provides online access to more than 12,000... Learn More -
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 4th Edition
$3,995.00Published by Kalorama Information on Jun 1st, 2010Kalorama Information’s Outsourcing in Drug Discovery offers unparalleled discussion of the drug discovery outsourcing market. It presents viewpoints from both customers and suppliers. Segments, size, and growth of the market... Learn More -
Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025
$2,461.00Published by Visiongain on May 5th, 2010In 2009, the biological (biologic) drug market generated over $125bn in revenues worldwide. There is great demand for lower-cost biological drugs. Commercial and regulatory developments will make biosimilars and... Learn More -
The Future of GPCRs in Drug Discovery: Novel technologies, leading companies, and opportunities for target expansion
$3,835.00Published by Business Insights on Apr 1st, 2010G-protein coupled receptors (GPCRs) constitute the largest, most ubiquitous, and most versatile family of membrane receptors. They also constitute the class of targets that has been most effectively exploited... Learn More -
Preclinical Models: Innovative solutions to accelerate drug discovery and development
$3,835.00Published by Business Insights on Feb 10th, 2010Preclinical models are developed to test lead compounds for toxicity and efficacy. They are valuable tools to minimize development costs and reduce failures prior to commencement of human trials. Problems... Learn More -
The Global Active Pharmaceutical Ingredients (API) Market: Evaluating challenges, opportunities, innovations and the market environment
$3,835.00Published by Business Insights on Feb 9th, 2010Active pharmaceutical ingredients (APIs), also known as ’bulk drug substances’, are defined by the US Food and Drugs Administration (FDA) as ’any substance or mixture of substances intended to be... Learn More -
Statins: The World Market 2010-2025
$2,461.00Published by Visiongain on Feb 8th, 2010The world statins market is facing rapid change. From 2010 onwards, there will be major patent expires - most notably for Lipitor - maturity of products, and rising competition from generic alternatives. Learn More -
Cytotoxic Therapies Market Forecast
$15,200.00Published by Datamonitor on Jun 29th, 2009The cytotoxics market is mature and characterized by an increasing level of genericization. Several blockbuster products will undergo patent expiry during the forecast period, however, by virtue of these drugs’ success, generic entry will ensure continued growth. Learn More